Category: Healthcare & Pharmaceuticals

Clinical Trials Healthcare & Pharmaceuticals News

AbbVie and Genmab Announce Positive Phase 3 Results for Epcoritamab in Relapsed/Refractory DLBCL

AbbVie

AbbVie and Genmab have announced significant topline results from the pivotal Phase 3 EPCORE® DLBCL-1 trial. The study marks a clinical milestone as the first Phase 3 trial to demonstrate a statistically significant improvement in progression-free survival (PFS) for a CD3xCD20 bispecific antibody monotherapy in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Clinical Trials Healthcare & Pharmaceuticals News Oncology

Johnson & Johnson Announces Landmark Phase 3 Results: TECVAYLI® Reduces Risk of Disease Progression or Death by 71% in Early Relapse Multiple Myeloma

JohnsonAndJohnson

Johnson & Johnson (NYSE: JNJ) today announced groundbreaking topline results from the Phase 3 MajesTEC-9 study, demonstrating that TECVAYLI® (teclistamab-cqyv) monotherapy significantly improves outcomes for [Read More…]

Artificial Intelligence Drug Discovery Healthcare & Pharmaceuticals News

NVIDIA and Lilly Unveil $1 Billion AI Lab to Revolutionize Drug Discovery

Eli Lilly and Company

NVIDIA and Eli Lilly have unveiled a landmark $1 billion partnership to launch a first-of-its-kind AI co-innovation lab in the San Francisco Bay Area. By co-locating world-class scientists and AI engineers, the collaboration aims to “industrialize” drug discovery through advanced foundation models, robotics, and “lab-in-a-loop” workflows.

Anti-obesity Drugs Business Healthcare & Pharmaceuticals News

Novo Nordisk Launches Oral Wegovy®, Marked as First-Ever GLP-1 Weight Loss Pill Available in the U.S.

Wegovy pill

Novo Nordisk has officially launched the Wegovy® pill, the first-ever oral GLP-1 medication for weight management in adults. Following FDA approval in late 2025, this once-daily pill offers a needle-free alternative to injections, demonstrating an average weight loss of up to 17% in clinical trials. With tiered pricing starting at $149 per month for self-pay patients, oral Wegovy is now available through major U.S. pharmacies and select telehealth platforms.